Cargando…
Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy
Background and study aims Response evaluation criteria in solid tumors (RECIST) have been the gold standard to preoperatively predict treatment response and prognosis in patients with gastric cancer (GC) after neoadjuvant chemotherapy (NAC); however, methods for patients without evaluable lesions b...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759937/ https://www.ncbi.nlm.nih.gov/pubmed/35047336 http://dx.doi.org/10.1055/a-1635-5855 |
_version_ | 1784633213497376768 |
---|---|
author | Shoji, Yoshiaki Nunobe, Souya Nishie, Naoki Yagi, Shusuke Makuuchi, Rie Ida, Satoshi Kumagai, Koshi Ohashi, Manabu Ishiyama, Akiyoshi Yoshio, Toshiyuki Hirasawa, Toshiaki Fujisaki, Junko Sano, Takeshi |
author_facet | Shoji, Yoshiaki Nunobe, Souya Nishie, Naoki Yagi, Shusuke Makuuchi, Rie Ida, Satoshi Kumagai, Koshi Ohashi, Manabu Ishiyama, Akiyoshi Yoshio, Toshiyuki Hirasawa, Toshiaki Fujisaki, Junko Sano, Takeshi |
author_sort | Shoji, Yoshiaki |
collection | PubMed |
description | Background and study aims Response evaluation criteria in solid tumors (RECIST) have been the gold standard to preoperatively predict treatment response and prognosis in patients with gastric cancer (GC) after neoadjuvant chemotherapy (NAC); however, methods for patients without evaluable lesions by RECIST are not yet confirmed. The aim of this study was to assess the utility of preoperative endoscopy for predicting treatment response and prognosis in patients with GC after NAC. Patients and methods This retrospective study included 105 patients with initially resectable GC who underwent NAC followed by surgical treatment. Preoperative factors for predicting treatment response and survival outcomes were analyzed. Results The number of patients classified as responders using preoperative endoscopic assessment, RECIST, and postoperative pathological evaluation were 25 (23.8 %), 28 (26.7 %), and 18 (17.1 %), respectively. Forty-three patients (41 %) were classified as non-targeted disease only, and their treatment responses were not evaluable by RECIST. Multivariate analysis identified endoscopic response as an independent preoperative factor to predict postoperative histological treatment response (odds ratio = 4.556, 95 % CI = 1.169–17.746, P = 0.029). Endoscopic treatment response was the only independent preoperative predictive factor for overall survival (OS) (hazard ratio = 0.419, 95 % confidence interval (CI) = 0.206–0.849, P = 0.016). Further, endoscopic treatment response was available for 33 patients (76.7 %) with non-targeted disease only, which showed significantly different OS between endoscopic responders (80.0 %) and non-responders (43.5 %) ( P = 0.025). Conclusions Endoscopic evaluation was an independent preoperative factor to predict treatment response and prognosis in patients with GC after NAC. Endoscopic assessment may be especially valuable for patients who could not be assessed by RECIST. |
format | Online Article Text |
id | pubmed-8759937 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-87599372022-01-18 Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy Shoji, Yoshiaki Nunobe, Souya Nishie, Naoki Yagi, Shusuke Makuuchi, Rie Ida, Satoshi Kumagai, Koshi Ohashi, Manabu Ishiyama, Akiyoshi Yoshio, Toshiyuki Hirasawa, Toshiaki Fujisaki, Junko Sano, Takeshi Endosc Int Open Background and study aims Response evaluation criteria in solid tumors (RECIST) have been the gold standard to preoperatively predict treatment response and prognosis in patients with gastric cancer (GC) after neoadjuvant chemotherapy (NAC); however, methods for patients without evaluable lesions by RECIST are not yet confirmed. The aim of this study was to assess the utility of preoperative endoscopy for predicting treatment response and prognosis in patients with GC after NAC. Patients and methods This retrospective study included 105 patients with initially resectable GC who underwent NAC followed by surgical treatment. Preoperative factors for predicting treatment response and survival outcomes were analyzed. Results The number of patients classified as responders using preoperative endoscopic assessment, RECIST, and postoperative pathological evaluation were 25 (23.8 %), 28 (26.7 %), and 18 (17.1 %), respectively. Forty-three patients (41 %) were classified as non-targeted disease only, and their treatment responses were not evaluable by RECIST. Multivariate analysis identified endoscopic response as an independent preoperative factor to predict postoperative histological treatment response (odds ratio = 4.556, 95 % CI = 1.169–17.746, P = 0.029). Endoscopic treatment response was the only independent preoperative predictive factor for overall survival (OS) (hazard ratio = 0.419, 95 % confidence interval (CI) = 0.206–0.849, P = 0.016). Further, endoscopic treatment response was available for 33 patients (76.7 %) with non-targeted disease only, which showed significantly different OS between endoscopic responders (80.0 %) and non-responders (43.5 %) ( P = 0.025). Conclusions Endoscopic evaluation was an independent preoperative factor to predict treatment response and prognosis in patients with GC after NAC. Endoscopic assessment may be especially valuable for patients who could not be assessed by RECIST. Georg Thieme Verlag KG 2022-01-14 /pmc/articles/PMC8759937/ /pubmed/35047336 http://dx.doi.org/10.1055/a-1635-5855 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Shoji, Yoshiaki Nunobe, Souya Nishie, Naoki Yagi, Shusuke Makuuchi, Rie Ida, Satoshi Kumagai, Koshi Ohashi, Manabu Ishiyama, Akiyoshi Yoshio, Toshiyuki Hirasawa, Toshiaki Fujisaki, Junko Sano, Takeshi Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy |
title | Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy |
title_full | Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy |
title_fullStr | Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy |
title_full_unstemmed | Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy |
title_short | Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy |
title_sort | impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759937/ https://www.ncbi.nlm.nih.gov/pubmed/35047336 http://dx.doi.org/10.1055/a-1635-5855 |
work_keys_str_mv | AT shojiyoshiaki impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy AT nunobesouya impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy AT nishienaoki impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy AT yagishusuke impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy AT makuuchirie impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy AT idasatoshi impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy AT kumagaikoshi impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy AT ohashimanabu impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy AT ishiyamaakiyoshi impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy AT yoshiotoshiyuki impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy AT hirasawatoshiaki impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy AT fujisakijunko impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy AT sanotakeshi impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy |